Search results
Author(s):
Gi-Byoung Nam
,
Min Soo Cho
Added:
10 months ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study…
View more
K Lance Gould
Job title: Martin Bucksbaum Distinguished University Chair, Professor and Director
Author
Prof José C Nicolau
Job title: Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS)
Author
Aleksander Siniarski
Author
William E Boden
Job title: Professor of Medicine
Author
Daniel JFM Thuijs
Research Area(s) / Expertise:
Author
Kalpa De Silva
Job title: Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
Author
Todd D Miller
Job title: Professor of Medicine, Division of Cardiovascular Disease, Department of Internal Medicine
Author
Stephen Dorman
Job title: Consultant Cardiologist
Author
Rafail Kotronias
Job title: MD
Author